pertussis antigens
PolandDrugs containing this active substance
-
The vaccine is used to boost protection against diphtheria, tetanus, and pertussis (whooping cough). It protects against diseases caused by the specific bacteria it is targeted against.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid not less than 2 IU (2 Lf)/0.5 ml tetanus toxoid not less than 20 IU (5 Lf)/0.5 ml pertussis antigens pertussis toxoid 2.5 mcg, filamentous hemagglutinin 5 mcg, pertactin 3 mcg, fimbriae type 2 and 3 5 mcg/0.5 ml ATC: J07AJ52
Manufacturer: Sanofi Winthrop Industrie Sanofi-Aventis Zrt.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Form: suspension for injection
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D diphtheria toxoid or equal to 30 IU tetanus toxoid or equal to 40 IU pertussis antigens 25 mcg + 25 mcg + 8 mcg ATC: J07CA02
Manufacturer: GlaxoSmithKline Biologicals S.A.